ckddb.com – Drug development platform for NAFLD – Analysis on Aug 09, 2025

Analysis performed on Aug 09, 2025

This is a comprehensive technical analysis of ckddb.com performed on August 9, 2025. The analysis includes DNS configuration, server information, WHOIS data, and HTTP response details.

Quick Navigation


🤖 AI Analysis Summary

1. Purpose and Target: The website explicitly states it is "a knowledge base and platform for drug development against non-alcoholic fatty liver disease (NAFLD)." It serves as a pharmaceutical knowledgebase and drug research and development platform focused on NAFLD and related conditions.

2. Location: Hosting/server information is provided: the web server runs on "nginx/1.24.0 (Ubuntu)."

3. Technology: Confirmed technologies include jQuery and Bootstrap as frontend frameworks, with the backend server identified as nginx running on Ubuntu.

4. SEO: Meta tags present include:
– Description: "NAFLDkb: a knowledge base and platform for drug development against non-alcoholic fatty liver disease"
– Keywords: "NAFLDkb, Non-Alcoholic Fatty Liver Disease, NAFLD; Metabolic associated fatty liver disease, MAFLD; Non-alcoholic steatohepatitis, NASH; Pharmaceutical knowledgebase; Drug research and development platform; Drug development against NAFLD; NAFLD drugs discovery; Repositioning drugs to target NAFLD"
– Author: "TJ_Xu, cadd@tongji"
– Robots: "all"

5. Security: The site uses HTTPS for secure connections. However, SSL certificate information could not be validated (marked invalid), but no specific security issues or exposed data were found.

6. Content Status: The site contains 198 words of content, more than the 50-word threshold, so the content is sufficient for analysis.

7. Accessibility: The website includes good accessibility features such as 95% of images having alt text and ARIA attributes present. It lacks skip navigation links and proper heading structure, but form input labels are properly used.

Summary: The website is an English-language platform focused on providing a knowledge base and drug development support specifically for non-alcoholic fatty liver disease. It is hosted on an nginx server running Ubuntu, uses jQuery and Bootstrap, and has relevant meta tags for SEO. HTTPS is enabled, but SSL certificate validity is unconfirmed. The site content is sufficient for analysis and includes good accessibility features.

In short: Drug development platform for NAFLD.

Back to Top ↑


🌐 Domain Information

The domain ckddb.com was registered on June 20, 2025, making it a newly registered domain with no prior history. It is currently active and set to expire on June 20, 2035. The registrar is DNSPod, Inc., and the domain is configured with nameservers HOT.DNSPOD.NET and POTATO.DNSPOD.NET.


WHOIS Registration Details

RegistrarDNSPod, Inc.
Registration Date2025-06-20
Expiration Date2035-06-20
Name ServersHOT.DNSPOD.NET
POTATO.DNSPOD.NET

Back to Top ↑


⚙️ Technical Data

The DNS configuration for ckddb.com includes an A record pointing to the IP address 120.79.196.190 and utilizes two name servers from dnspod.net. The site has HTTPS enabled; however, the SSL certificate is invalid and lacks proper implementation details. The technology stack comprises nginx version 1.24.0 on Ubuntu, along with front-end technologies such as jQuery and Bootstrap.

DNS Records

A Records

HostIP AddressTTL
@120.79.196.190595

NS Records

HostTargetTTL
ckddb.comhot.dnspod.net7194
ckddb.compotato.dnspod.net7194

SSL & Security

HTTPS Status✅ Enabled
HSTS⚠️ Not Enabled
Security SummaryThe website uses HTTPS for secure connections.

Technologies

Server Softwarenginx/1.24.0 (Ubuntu)
Detected TechnologiesjQuery, Bootstrap
Technology SummaryThe website uses technologies including jQuery, Bootstrap. Server: nginx/1.24.0 (Ubuntu).

Content Information

Content Size198 words
Meta DescriptionNAFLDkb: a knowledge base and platform for drug development against non-alcoholic fatty liver disease
Meta KeywordsNAFLDkb, Non-Alcoholic Fatty Liver Disease, NAFLD; Metabolic associated fatty liver disease, MAFLD; Non-alcoholic steatohepatitis, NASH; Pharmaceutical knowledgebase; Drug research and development platform; Drug development against NAFLD; NAFLD drugs discovery; Repositioning drugs to target NAFLD
Content AnalysisThe site contains 198 words of content. It has proper meta tags for SEO.

HTTP Status Information

Redirect Chain
Response Time0 ms

Back to Top ↑